How common is hyperostosis frontalis interna (HFI) in 70-year-old women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hyperostosis Frontalis Interna (HFI) is Common in 70-Year-Old Women

HFI occurs in approximately 16-18% of women aged 70 years, making it a relatively common age-related finding in this demographic.

Prevalence Data

The prevalence of HFI in 70-year-old women is well-documented in the research literature:

  • In women aged 65+ years: The prevalence reaches approximately 16.4% in the oldest age group (>65 years) 1
  • Overall rate in elderly women: Studies show an 18.14% occurrence rate in deceased females with an average age of 68.3 years 2
  • Age-dependent progression: Unlike men, women demonstrate a clear age-related increase in HFI prevalence, with the condition being significantly more common after menopause 1, 3

Sex and Age Differences

The epidemiology of HFI shows striking demographic patterns:

  • Female predominance: HFI is overwhelmingly more common in women, with 87.5% of severe cases occurring in females over 65 years old 4
  • Male comparison: Men show minimal age-related changes in frontal bone thickness and have significantly lower HFI rates across all age groups 1
  • Postmenopausal association: The condition is particularly prevalent in postmenopausal women, suggesting hormonal influences 4, 5

Clinical Context

Age is a predicting factor for HFI occurrence specifically in females 3. Women younger than 55 years have similar (low) risk as males, but this risk increases substantially with advancing age. The frontal bone thickness in women becomes progressively greater with age (Spearman's Rho 0.11; p≤0.01), while no such correlation exists in men 1.

Important Caveats

  • Asymptomatic nature: Most HFI cases are incidentally discovered, as the condition is often asymptomatic
  • Severity classification: The 16-18% prevalence includes all grades of HFI; severe forms (Type D) are less common but still predominantly affect elderly women
  • Slow progression: HFI progresses at approximately 3 years per millimeter of bone thickness, meaning it develops gradually over decades 6

The total prevalence across all age groups and both sexes is approximately 8.1-12.5% 1, 4, but this figure is heavily skewed by the high prevalence in elderly women, making 70-year-old women a particularly affected demographic.

Related Questions

What is a hyperostosis presenting as a raised bony exostosis on the vertex of the skull along the suture line, extending posteriorly about 3 inches?
In a 70-year-old woman with hyperostosis frontalis interna (HFI) presenting with new-onset headache, how frequently is HFI associated with meningioma?
Can sustained pressure from hyperostosis along the sagittal suture cause localized hair thinning?
In a patient with hyperostosis over the thymus, is there any relationship to hyperostosis of the sagittal suture?
What are the possible causes of a midline calvarial bony exostosis extending from the frontal region toward the posterior?
What is the appropriate dosing of Flonase (fluticasone propionate) 50 µg versus 93 µg spray for a 12‑year‑old patient?
What is the recommended initial regimen, dosing, device technique, and follow‑up for starting a patient on low‑dose inhaled corticosteroids (e.g., budesonide) for asthma or COPD?
For a patient with COPD who continues to have dyspnea or frequent exacerbations despite a single long‑acting bronchodilator, or for a patient with asthma uncontrolled on low‑dose inhaled corticosteroid, which fixed‑dose LABA/LAMA (long‑acting β₂‑agonist/long‑acting muscarinic antagonist) inhaler combination is recommended, how should it be used, and what follow‑up is required?
What is the recommended oral dose of codeine for cough in a typical healthy adult, including dosing frequency and maximum daily amount?
What is the appropriate prescription for an adult with streptococcal infection who has a penicillin (PCN) allergy?
How long can a patient with ulcerative colitis go without medical treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.